This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Colitis, Ulcerative
and you are
between 18 and 70
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

study to investigate the safety and efficacy properties of PF-00547659 in patients with active ulcerative colitis

Provided treatments

  • Biological: Single dose-group A
  • Biological: Single dose-group A
  • Biological: Multiple dose- Group B
  • Biological: Single dose-group A
  • Biological: Multiple dose- Group B
  • Biological: Single dose-group A
  • Biological: Single dose-group A
  • Biological: Single dose-group A
  • Biological: Single dose-group A
  • Biological: Multiple dose-Group B
  • Biological: Multiple dose- Group B
  • Biological: Multiple dose- Group B
  • Biological: Multiple dose- Group B
  • Biological: Multiple dose- Group B
  • Biological: Multiple dose-Group B
Tris trial is registered with FDA with number: NCT00928681. The sponsor of the trial is Pfizer and it is looking for 80 volunteers for the current phase.
Official trial title:
A Randomized, Double-Blind (Sponsor Open), Placebo Controlled, Dose Escalating, Parallel Group, Multi-Centre Study To Investigate The Safety, Toleration, Pharmacokinetics And Pharmacodynamics Of Single And Multiple Intravenous/Sub-Cutaneous Doses Of PF-00547659 In Patients With Active Ulcerative Colitis.